Loading...
Loading...
Browse all stories on DeepNewz
VisitStudy Finds mRNA COVID-19 Vaccine Linked to 60 Times Higher Heart Disease Risk; CDC Recommends 3 Doses for Infants 6 Months and Older
Oct 30, 2024, 11:12 AM
A recent peer-reviewed study indicates that individuals who received one dose of an mRNA COVID-19 vaccine have a higher risk of acute heart disease compared to those who received a non-mRNA vaccine. This finding raises concerns about the safety of mRNA vaccines, particularly in young males. Additionally, the FDA has been criticized for allegedly overestimating the benefit-risk ratio of the mRNA vaccine for males aged 18-25 by more than 60 times, based on new data regarding Omicron and myocarditis. The CDC's new guidelines recommend that infants aged 6 months and older receive three COVID-19 vaccinations, despite claims that there is insufficient scientific evidence demonstrating a reduction in hospitalizations or deaths. Critics argue that this recommendation may contribute to growing public distrust in health authorities, as the hospitalization and death rates from COVID-19 among infants and children are low. Furthermore, some experts suggest that natural immunity may be effective and that vaccines do not necessarily prevent the spread of the virus.
View original story
Pfizer • 25%
Moderna • 25%
Novavax • 25%
Other • 25%
Novavax • 25%
Moderna • 25%
Pfizer • 25%
Other • 25%
Increase • 33%
Decrease • 33%
Remain the same • 34%
Self-administration nasal spray • 25%
Traditional injection • 25%
Pharmacy-administered nasal spray • 25%
Other methods • 25%
GeoVax COVID-19 vaccine • 33%
Moderna mRNA influenza vaccine • 33%
Pfizer COVID-19 vaccine • 33%
Yes • 50%
No • 50%
Pfizer-BioNTech • 25%
Moderna • 25%
Novavax • 25%
Other • 25%
Children (6 months to 11 years) • 25%
Adolescents (12 to 17 years) • 25%
Adults (18 to 64 years) • 25%
Seniors (65 years and older) • 25%
Increase significantly • 25%
Decrease significantly • 25%
Remain stable • 25%
Fluctuate • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No significant change • 25%
Other outcome • 25%
Increased trust • 25%
Decreased trust • 25%